Back to search
Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma trials you may qualify forThis is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor an NTRK1/2…
The study will primarily assess the antitumor activity of crizotinib in a variety of tumors with alterations in ALK and/or MET pathways. The targeted patient po…
This study will evaluate the efficacy and safety of alectinib in participants with Anaplastic Lymphoma Kinase (ALK)-positive locally advanced or metastatic soli…